Home » » Docs Light Up Cancer.

Docs Light Up Cancer.

http://www.foxnews.com/health/2011/10/05/fda-adds-fertility-risk-warning-to-av
Treatment with Roche Holding AG's cancer drug Avastin might affect fertility in some women, the

The agency said a new warning about the risk of "ovarian failure" was added to Avastin's label and

Avastin is approved to treat certain types of lung, brain, kidney, colon and breast cancers. However, in the U.S., the company is fighting to keep the FDA from revoking the approval for

The FDA and companies routinely revise drug labels when there are new clinical data or side-effects seen in post-marketing event reports.

In a statement, Roche's Genentech unit, which

The information on ovarian failure came from a clinical trial involving the use of Avastin in a study of 179 women with

Ovarian function returned in about 20 percent of the women after treatment with Avastin was stopped.

"Long-term effects of Avastin exposure on fertility are unknown," FDA said.

Read more:
as
Share this article :

0 comments:

Post a Comment

 
Copyright © Health Bulletin - All Rights Reserved
Proudly powered by Blogger